CanadaBuys #W6369-26-A033/B

Canadian Department of National Defence Solicits Pralidoxime for Chemical Warfare Treatment

The Department of National Defence (DND), Government of Canada, is seeking suppliers for Pralidoxime Chloride or Pralidoxime Methyl Sulfate to treat Canadian Armed Forces members exposed to chemical warfare agents. - Government Buyer: - Department of National Defence, Canadian Forces Health Services Group - Strategic Medical Countermeasures Program - Director Services Contracting (D Svcs C) 3 - Products Requested: - Pralidoxime Chloride or Pralidoxime Methyl Sulfate - 450 treatment courses (initial delivery) - Up to 600 optional treatment courses (150 per year for 4 years) - Each course: 200 mg per primary container, sterile solution or powder for injection - Suitable for intravenous or intramuscular administration - Must comply with Health Canada Notice of Compliance or Division 11 authorization - Minimum 30 months shelf-life upon delivery - Packaging must include product name, strength, lot/batch number, expiry/manufacture date - Strict temperature-controlled transport requirements - OEMs and Vendors: - No specific OEMs named; solicitation open to Canadian and eligible international suppliers - Unique/Notable Requirements: - Product must be authorized by Health Canada - Delivery to Central Medical Equipment Depot, Petawawa, Ontario - Optional requirements for environmentally friendly packaging - No security requirements; submissions accepted in English or French - Annual optional deliveries through contract period - Contract Duration: - Estimated 52 months, with initial and optional annual deliveries

Description

The Department of National Defence (DND), through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, requires Pralidoxime for treating Canadian Armed Forces members suspected of exposure to chemical warfare agents. The initial order is for 450 doses to be delivered before March 31, 2027, with optional orders of 600 doses between April 1, 2027, and March 31, 2031. The contract duration is estimated at 52 months starting November 27, 2026. There are no security requirements, and submissions can be in either official language of Canada.

View original listing